Dr. Tanya Dorff, MD
Claim this profileCity of Hope Medical Center
Expert in Prostate Cancer
Studies Cancer
15 reported clinical trials
37 drugs studied
Area of expertise
1Prostate Cancer
Global LeaderStage IV
PSCA
Progression
2Cancer
Stage IV
PSCA
Progression
Affiliated Hospitals
Clinical Trials Tanya Dorff, MD is currently running
Pembrolizumab + Lenvatinib
for Neuroendocrine Prostate Cancer
This trial uses a combination of two drugs, lenvatinib and pembrolizumab, to treat patients with cancer that hasn't responded to other treatments. Lenvatinib stops cancer cells from growing, while pembrolizumab helps the immune system attack the cancer. The combination received accelerated FDA approval in September 2019 for all patients with advanced endometrial cancer who have disease progression following previous treatments. The treatment cycles last a few weeks and can continue for several months unless there are side effects or other reasons to stop.
Recruiting1 award Phase 22 criteria
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
More about Tanya Dorff, MD
Clinical Trial Related7 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Tanya Dorff, MD has experience with
- Abiraterone Acetate
- Prednisone
- Apalutamide
- Enzalutamide
- Pembrolizumab
- Bicalutamide
Breakdown of trials Tanya Dorff, MD has run
Prostate Cancer
Cancer
Prostate Adenocarcinoma
Transitional Cell Carcinoma
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tanya Dorff, MD specialize in?
Tanya Dorff, MD focuses on Prostate Cancer and Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are PSCA.
Is Tanya Dorff, MD currently recruiting for clinical trials?
Yes, Tanya Dorff, MD is currently recruiting for 8 clinical trials in Duarte California. If you're interested in participating, you should apply.
Are there any treatments that Tanya Dorff, MD has studied deeply?
Yes, Tanya Dorff, MD has studied treatments such as Abiraterone Acetate, Prednisone, Apalutamide.
What is the best way to schedule an appointment with Tanya Dorff, MD?
Apply for one of the trials that Tanya Dorff, MD is conducting.
What is the office address of Tanya Dorff, MD?
The office of Tanya Dorff, MD is located at: City of Hope Medical Center, Duarte, California 91010 United States. This is the address for their practice at the City of Hope Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.